Adaptin Bio, Inc. Cash and Restricted Cash
Adaptin Bio, Inc. (APTN) had Cash and Restricted Cash of $670.49 thousand as of 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-28
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $670.49K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $301.31K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $459.17K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $579.09K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $670.49K S-1 · filed 2026-08-28 | |
| 2026-03-31 | $301.31K POS AM · filed 2026-07-21 | |
| 2025-12-31 | $459.17K S-1 · filed 2026-08-28 | |
| 2025-09-30 | $579.09K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.35M S-1 · filed 2026-08-28 | |
| 2025-03-31 | $2.37M POS AM · filed 2026-07-21 | |
| 2024-12-31 | $34.09K S-1 · filed 2026-08-28 | $12.62K 10-K · filed 2025-04-15 |
| 2024-09-30 | $115.31K 10-Q · filed 2025-11-14 | $322.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $23.78K 10-Q · filed 2025-08-14 | $322.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.06K 10-Q · filed 2025-05-15 | $380.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.75K S-1 · filed 2026-08-28 | $380.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $380.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $500.00 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $500.00 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $500.00 10-K · filed 2025-04-15 |